GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
BERGER, SCOTT B.,GOUGH, PETER J.,WEISEL, KATHLEEN M.
申请号：
CA2958645
公开号：
CA2958645A1
申请日:
2015.08.20
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Disclosed is a method of treating a RIP1 kinase-mediated disease or disorder which comprises administering a therapeutically effective amount of a compound that inhibits RIP1 kinase and at least one other therapeutically active agent to a patient in need thereof.
